Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

Deep Learning in Structure-Based Drug Design

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Structure-based drug design with geometric deep learning

Structure-based drug discovery with deep learning

De Novo Structure-Based Drug Design Using Deep Learning

Deep Machine Learning for Computer-Aided Drug Design

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

Recent Progress of Deep Learning in Drug Discovery

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Geometric deep learning methods and applications in 3D structure-based drug design

Deep Learning in Drug Design—Progress, Methods, and Challenges

Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design

Advances in De Novo Drug Design: From Conventional to Machine Learning Methods

A Review Of Deep Learning In Computer-Aided Drug Design

Deep learning tools for advancing drug discovery and development

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

Recent Trends in Drug Design and Discovery

Systems-Structure-Based Drug Design

Deep Learning Approaches for &lt;italic&gt;de Novo&lt;/italic&gt; Drug Design: an Overview